Recent news on Zonegran

Eisai Signs Exclusive Agreement to Commercialize NeuroBloc for Europe  -  May 15, 2007
PharmaLive.com (press release),...with its global products including Aricept® (symptomatic treatment of Alzheimer’s disease) as well as the anti-epilepsy agents Zonegran® and Inovelon®.

Japan's Eisai soars on back of healthy sales and patent win  -  May 16, 2007
Pharma Times (subscription),However sales of the anti-epileptic Zonegran (zonisamide) slumped 62.6% to 4.9 billion yen, cannibalised by generics. In terms of pipeline, Eisai noted that

Identifying hospitalized first clinical in economic issued.  -  Apr 16, 2007
Journal lycéen,The actual require greater rapid changes with strong Zonegran consumers. China in recovery is tubular function Hycodan vesicles.

Elan Reports First Quarter 2007 Financial Results  -  Apr 24, 2007
PharmaLive.com (press release),...failure to comply with kickback and false claims laws including in respect to past practices related to the marketing of Zonegran which are being

Elan facing 'kick-back' probe  -  Mar 3, 2007
Unison.ie (subscription),The investigation into Elan involves the promotion of its former Zonegran drug, which it sold to rival pharma group Eisai almost three years ago.

Eisai India seeks local partners to market drug  -  Mar 2, 2007
Daily News & Analysis,Apart from Myonal, Eisai’s other drugs like Clevudin (anti-hepatitis B agent) and Zonegran (anti-epilepsy) have completed clinical trials and are waiting

Eisai begins building its first European production plant  -  Mar 6, 2007
In-PharmaTechnologist.com,...including Aricept, used in the treatment of Alzheimer's disease, Pariet, a PPI used in the treatment of gastro-intestinal disorders, and Zonegran,

Eisai Announces Inovelon(R) Receives Marketing Authorization ...  -  Jan 28, 2007
Medical News Today (press release),...its neurology franchise which includes Aricept(R) (donepezil) for treatment of Alzheimer's disease and anti-epilepsy agent Zonegran(R)(zonisamide).

Eisai's Zonegran Improved Parkinson's Symptoms, Study Finds  -  Jan 1, 2007
Bloomberg...s Zonegran epilepsy treatment reduced tremors and other involuntary movements in patients with Parkinson's disease, a disorder of the brain, a study found.

Antiepileptic Reduces Parkinson's Symptoms Safely  -  Jan 2, 2007
MedPage Today,2 -- Tremors and other symptoms associated with Parkinson's disease can be reduced significantly by the antiepileptic drug Zonegran (zonisamide) without an

Epilepsy Drug May Treat Parkinson's  -  Jan 4, 2007
WebMDZonisamide is sold in the US generically and under the brand name Zonegran. In Parkinson's diseaseParkinson's disease, the brain cells that make dopamine,

Schwarz Pharma says epilepsy drug reduces seizures  -  Dec 4, 2006
ReutersN: Quote, Profile , Research) Topamax and Zonegran, sold by Dainippon Pharmaceutical USA Corp., have led some patients to complain of confusion,

Elan Q3 Loss Widens, Revenues Decline On Maxipime Supply Shortages ...  Oct 25, 2006
Therapeutics. Further, the company noted that the year-ago results were propped up by a gain of $23 million from the sale of Zonegran. ... -Trading Markets, Elan Posts Wider Loss In Q3 On Lower Revenues; Maintains FY06 ...  Oct 25, 2006
The net loss for the current-year quarter included a gain of $23.0 million on the sale of Zonegran in 2005, share-based compensation expense of $10.9 million ... -Trading Markets, Elan Reports Third Quarter 2006 Financial Results  Oct 24, 2006
The increase in net loss is principally due to a gain of $23.0 million on the sale of Zonegran(TM) in 2005, the inclusion of share-based compensation expense ... -Genetic Engineering News (press release), Losses widen, sales dip at Elan despite rollout of key MS drug ...  Oct 25, 2006
...temporary supply problems for its injected antibiotic Maxipime; the US$23 million (€18.3 million) sale in 2005 of a drug called Zonegran; and changes in ... -International Herald Tribune, Foro de Shell Security - Seguridad informática  Oct 27, 2006
...of acute lymphobla zomig tic lymphoma, a very aggressive form of NHL, i zone-a usually patterned after acute lymphoblastic leukemia (ALL) t zonegran erapy. ... -Shell Security, Off-label drugs a risky Rx for slimming down  Sep 10, 2006
...to treat attention-deficit (hyperactivity) disorder (Adderall and Ritalin), depression (Wellbutrin), epilepsy (Topamax and Zonegran), diabetes (Glucophage and ... -Fort Wayne Journal Gazette

Eisai Announces Establishment of New Pharmaceuticals Marketing ...  -  Nov 21, 2006
PharmaLive.com (press release),...with the launch of its neurology products including the anti-epileptic drugs Zonegran® and Inovelon® (for which Eisai received positive opinion for

Schwarz Pharma says epilepsy drug reduces seizures  -  Dec 4, 2006
ReutersN: Quote, Profile , Research) Topamax and Zonegran, sold by Dainippon Pharmaceutical USA Corp., have led some patients to complain of confusion,

Eisai Recieves Positive Opinion For Inovelon(R) Marketing ...  -  Nov 23, 2006
Medical News Today (press release),...its neurology franchise which includes Aricept(R)(donepezil) for treatment of Alzheimer's disease and anti-epilepsy agent Zonegran(R)(zonisamide).

Elan Reports Second Quarter 2006 Financial Results  Jul 31, 2006
...offset by the impact of expensing share-based compensation in the second quarter of 2006 and the inclusion in 2005 of a gain on the divestment of Zonegran(TM). ... -Business Wire

Teva/Eisai: the End of an Alliance  Jul 13, 2006
...hydrochloride), and recently expanded the number of specialist sales representatives following the acquisition of Elan's migraine drug, Zonegran (zonisamide). ... -International News Service

Eisai Inc. Announces Appointment of Vice President of Business ...  Jul 6, 2006
...he has played a key role in the successful conclusion of deals with Pfizer for an anti-coagulant, Dainippon for AS-3201, Elan for Zonegran(R) (zonisamide ... -PR Newswire



Elan Reports First Quarter 2006 Financial Results  May 3, 2006
...rights to Eisai Co., Ltd (Eisai) while the 2005 net loss included a gain of $42.0 million of consideration related to the divestment of Zonegran(TM) (zonisamide ... - Business Wire

Ask the Clinician: Answers to Readers' Questions  Apr 24, 2006
They did not help. My Doctor would like me to try Zonegran. ... Do you know if Zonegran has been an effective preventative drug for migraines? ... - About - News & Issues

Elan's Q1 Net Loss Narrows On Higher Revenues, Margin Improvement ...  May 4, 2006
First quarter of 2005 included a gain of $42.0 million related to the divestment of antiseizure drug Zonegran to Eisai in April 2004. ... - Trading Markets





TEVA USA Introduces Zonisamide Capsules  Apr 4, 2006
This product is AB rated and bioequivalent to Zonegran®*. ... Zonegran® is a registered trademark of the Dainippon Pharmaceutical Co. - PharmaLive.com

European Stocks May Drop on Renewed Rate Concern; BP May Fall  Mar 30, 2006
Elan said the Justice Department and the Health and Human Services sent the subpoena in January over the marketing of the Zonegran epilepsy drug. ... - Bloomberg



Elan Sells European Prialt Rights To Eisai For $100M  Feb 9, 2006
In April 2004, Elan sold exclusive North American and European manufacturing, development and marketing rights for Zonegran (zonisamide) to Eisai for $130 ... - BioWorld Online (subscription),

First-Time Generic Approvals: Zithromax, Cefzil, Zonegran  Jan 27, 2006
Apotex Inc, Sandoz Inc, Barr Laboratories Inc, Roxane Laboratories Inc, Dr. Reddy's Laboratories Limited, and Wockhardt Limited; brand name Zonegran, made by ... - Medscape (subscription)

Elan meldt financiële resultaten vierde kwartaal en hele jaar ...  Jan 31, 2006
Total Product Revenue from Core 100.3 132.7 Business 339.4 456.4 Revenue from Divested Products -- -- European business 10.5 -- -- - Zonegran(TM) 41.2 -- 2.0 ... - Netherlands Corporate News (persbericht)

Eisai chooses UK for key European base  Feb 2, 2006
...including Aricept, used in the treatment of Alzheimer's disease, Pariet, a PPI used in the treatment of gastro-intestinal disorders, and Zonegran, for the ... - OutSourcing-Pharma.com

This site is for informational purposes only--it does not offer medical advice or sell health products. If you need assistance, contact your physician or healthcare professional